Loyal Advances First Canine Longevity Drug as FDA Accepts Safety Review for LOY-002
Loyal has reached a major regulatory milestone as the FDA accepts the Target Animal Safety section for LOY-002, bringing the company closer to launching the first drug intended to extend the healthy lifespan of dogs.